SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001193125-24-157513
Filing Date
2024-06-07
Accepted
2024-06-07 17:04:56
Documents
4

Document Format Files

Seq Description Document Type Size
1 424B5 d835187d424b5.htm 424B5 275960
2 EX-FILING FEES d835187dexfilingfees.htm EX-FILING FEES 19682
3 GRAPHIC g835187g00w78.jpg GRAPHIC 591674
4 GRAPHIC g835187g01q44.jpg GRAPHIC 53658
  Complete submission text file 0001193125-24-157513.txt   1178083
Mailing Address 5858 HORTON STREET #455 EMERYVILLE CA 94608
Business Address 5858 HORTON STREET #455 EMERYVILLE CA 94608 5105052680
4D Molecular Therapeutics, Inc. (Filer) CIK: 0001650648 (see all company filings)

IRS No.: 473506994 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-276872 | Film No.: 241030532
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)